Tenax Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 11/14/2025 | 967.60 K | $7.36 M | 100.00% | 2.45% |
| VR ADVISER, LLC | 11/14/2025 | 437.71 K | $3.33 M | 344.09% | 1.11% |
| RTW INVESTMENTS, LP | 11/14/2025 | 378.35 K | $2.88 M | 0.00% | 0.96% |
| SIREN, L.L.C. | 11/13/2025 | 352.44 K | $2.68 M | 100.00% | 0.89% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 352.21 K | $2.68 M | 100.00% | 0.89% |
| BVF INC/IL | 11/14/2025 | 339.55 K | $2.58 M | 0.00% | 0.86% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 313.71 K | $2.39 M | 34.23% | 0.79% |
| VIVO CAPITAL, LLC | 11/14/2025 | 208.33 K | $1.59 M | 0.00% | 0.53% |
| MORGAN STANLEY | 11/14/2025 | 178.33 K | $1.36 M | 0.18% | 0.45% |
| MARSHALL WACE, LLP | 11/13/2025 | 177.21 K | $1.35 M | 100.00% | 0.45% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 167.00 K | $1.27 M | 0.00% | 0.42% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 166.67 K | $1.27 M | 0.00% | 0.42% |
| VANGUARD GROUP INC | 11/07/2025 | 161.80 K | $1.23 M | 625.98% | 0.41% |
| WOODLINE PARTNERS LP | 11/14/2025 | 88.21 K | $671.29 K | 100.00% | 0.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 83.33 K | $634.16 K | 0.00% | 0.21% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 83.33 K | $634.16 K | 0.00% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 56.60 K | $430.73 K | 100.00% | 0.14% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 53.44 K | $406.67 K | 0.00% | 0.14% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 53.43 K | $406.59 K | -65.65% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2025 | 43.25 K | $329.16 K | 318.11% | 0.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 34.43 K | $261.97 K | 0.55% | 0.09% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 12.12 K | $92.00 K | 100.00% | 0.03% |
| DRW SECURITIES, LLC | 11/14/2025 | 10.51 K | $80.01 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 501 | $3.81 K | -59.89% | 0.00% |
| BLACKROCK, INC. | 11/12/2025 | 301 | $2.29 K | 0.33% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 254 | $1.93 K | 2.01% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 119 | $906 | 750.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 2 | $15 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 2 | $15 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 1 | $8 | 0.00% | 0.00% |
| WEALTHSPIRE ADVISORS, LLC | 11/14/2025 | 1 | $8 | 100.00% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 11/04/2025 | 1 | $8 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 1 | $7 | 0.00% | 0.00% |
| UNION BANCAIRE PRIVEE, UBP SA | 10/07/2025 | 1 | $6 | 0.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Tenax Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of Tenax Therapeutics, Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 967,600
VR Adviser, LLC: 437,708
RTW INVESTMENTS, LP: 378,346
Siren, L.L.C.: 352,441
BOOTHBAY FUND MANAGEMENT, LLC: 352,206
BVF INC/IL: 339,549
11.93% of Tenax Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.73 M shares in the last 24 months. This purchase volume represents approximately $35.47 M in transactions.